BioAtla, Inc.
BCAB
$1.23
-$0.03-2.38%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 6.50M | -- | 2.00M | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.50M | -- | 2.00M | -- | -- |
| Cost of Revenue | 3.34M | 4.18M | 8.00M | 9.54M | 13.68M |
| Gross Profit | 3.16M | -4.18M | -6.00M | -9.54M | -13.68M |
| SG&A Expenses | 2.93M | 4.63M | 3.26M | 4.25M | 4.96M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.27M | 8.81M | 11.26M | 13.79M | 18.65M |
| Operating Income | 227.00K | -8.81M | -9.26M | -13.79M | -18.65M |
| Income Before Tax | 452.00K | -6.34M | -9.78M | -15.78M | -18.71M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 452.00K | -6.34M | -9.78M | -15.78M | -18.71M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 452.00K | -6.34M | -9.78M | -15.78M | -18.71M |
| EBIT | 227.00K | -8.81M | -9.26M | -13.79M | -18.65M |
| EBITDA | 227.00K | -8.69M | -9.24M | -13.73M | -18.53M |
| EPS Basic | 0.27 | -4.22 | -8.18 | -13.43 | -15.99 |
| Normalized Basic EPS | 0.17 | -2.43 | -5.11 | -8.39 | -9.99 |
| EPS Diluted | 0.27 | -4.22 | -8.18 | -13.43 | -15.99 |
| Normalized Diluted EPS | 0.17 | -2.43 | -5.11 | -8.39 | -9.99 |
| Average Basic Shares Outstanding | 1.66M | 1.50M | 1.20M | 1.17M | 1.17M |
| Average Diluted Shares Outstanding | 1.66M | 1.50M | 1.20M | 1.17M | 1.17M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |